| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/27/2008 | CA2662065A1 Dbait and uses thereof |
| 03/27/2008 | CA2660856A1 Prophylactic and therapeutic treatment of avian influenza infections in animals |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903112A2 Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1903058A2 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903056A2 HLA-A1, -A2 -A3, -A24, -B7, and -B44 tumor associated antigen peptides and compositions |
| 03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
| 03/26/2008 | EP1903053A1 Elastin production-enhancing agents |
| 03/26/2008 | EP1903033A1 Coniosetine, process for preparation and use as pharmaceutical |
| 03/26/2008 | EP1902734A1 uPAR selective contrast agent for magnetic resonance imaging |
| 03/26/2008 | EP1902732A1 Prophylactic/therapeutic agent for her2-expressing cancer |
| 03/26/2008 | EP1902730A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea |
| 03/26/2008 | EP1902725A2 Revascularization of ischemic retinal tissue |
| 03/26/2008 | EP1902724A2 Antimicrobial compositions |
| 03/26/2008 | EP1902719A2 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 03/26/2008 | EP1902318A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis |
| 03/26/2008 | EP1902314A1 Method for evaluating the effects of smoke on bronchioles |
| 03/26/2008 | EP1902141A1 Adamts13-comprising compositions having thrombolytic activity |
| 03/26/2008 | EP1902065A2 Cyclic amide derivatives inhibitors of the inhibitor of apoptosis proteins, their preparation, and their use |
| 03/26/2008 | EP1901775A2 Kinin antagonists for treating bladder dysfunction |
| 03/26/2008 | EP1901773A2 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection |
| 03/26/2008 | EP1901772A2 Lysozyme-based food stuff |
| 03/26/2008 | EP1901771A2 Nattokinase for reducing whole blood viscosity |
| 03/26/2008 | EP1901770A2 Methods for treatment of growth disorders |
| 03/26/2008 | EP1901769A2 Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease |
| 03/26/2008 | EP1901768A1 Methods of modulating il-23 activity; related reagents |
| 03/26/2008 | EP1901767A2 Methods and systems for neural maintenance and regeneration |
| 03/26/2008 | EP1901766A2 Use of fril proteins for reducing the production of pro-inflammatory cytokines |
| 03/26/2008 | EP1901764A1 Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart |
| 03/26/2008 | EP1901763A2 Thyrotropin-releasing hormone analogs and method of use |
| 03/26/2008 | EP1901762A2 Use of one or more metal carriers to selectively kill mammalian cells |
| 03/26/2008 | EP1901761A2 Thrombospondin-1 derived peptides and treatment methods |
| 03/26/2008 | EP1901760A2 Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells |
| 03/26/2008 | EP1901759A1 Immunostimulatory method |
| 03/26/2008 | EP1901755A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 03/26/2008 | EP1901711A2 Cyclosporin compositions |
| 03/26/2008 | EP1701974B1 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments |
| 03/26/2008 | EP1663294B1 Treatment of fibrotic disease |
| 03/26/2008 | EP1620072B1 Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 03/26/2008 | EP1613337A4 Acute respiratory syndromes |
| 03/26/2008 | EP1610811A4 Prevention and treatment of cardiac arrhythmias |
| 03/26/2008 | EP1604014A4 Gene expression in breast cancer |
| 03/26/2008 | EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/26/2008 | EP1458866B1 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | EP1179068B1 Interleukin-1 hy2 materials and methods |
| 03/26/2008 | EP1090128B1 Modified vitamin-k-dependent polypeptides |
| 03/26/2008 | EP1033953B1 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 03/26/2008 | EP0923553B1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl compounds |
| 03/26/2008 | EP0917535B1 Neuroactive peptide |
| 03/26/2008 | EP0885242B1 Peptides and compounds that bind to a thrombopoietin receptor |
| 03/26/2008 | EP0714405B1 Therapeutic and diagnostic agents for amyloidosis |
| 03/26/2008 | EP0672147B1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 03/26/2008 | CN101151533A Procoagulants based on metal-chelating lipids |
| 03/26/2008 | CN101151280A Immunogenic molecules |
| 03/26/2008 | CN101151272A Recombinant icosahedral virus like particle production in pseudomonads |
| 03/26/2008 | CN101151049A Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 03/26/2008 | CN101151048A Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 03/26/2008 | CN101151047A Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin |
| 03/26/2008 | CN101151046A Anti-viral agent |
| 03/26/2008 | CN101151045A Methods for suppressing neovascularization using EphrinB2 |
| 03/26/2008 | CN101151044A Composition comprising beta-defensin 2 |
| 03/26/2008 | CN101151043A Composition and methods for promoting wound healing and tissue regeneration |
| 03/26/2008 | CN101151030A Combinations comprising at least one direct thrombin inhibitor for the treatment of thrombosis |
| 03/26/2008 | CN101151025A Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 03/26/2008 | CN101150954A Methods and compositions for encapsulation of cells |
| 03/26/2008 | CN101148659A Method of preparing recombination human source catalase and application thereof |
| 03/26/2008 | CN101148478A Streptavidin-tumour putrescence factor alpha fusion protein |
| 03/26/2008 | CN101148477A Streptavidin-interleukins 2 fusion protein |
| 03/26/2008 | CN101148476A Inflammation related disease target treatment fusion protein |
| 03/26/2008 | CN101148473A Recombination human insulin and its coding gene and application |
| 03/26/2008 | CN101148472A Tumour inhibitory gene or protein and application thereof |
| 03/26/2008 | CN101148470A Antibacterial/neutral endotoxin allosteric peptide molecule modified by polyglycol, synthesizing method and medical use thereof |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN101147802A Composition for treating knee-joint cross ligament damage |
| 03/26/2008 | CN101147801A Application of dexoyribozyme of target EBV-LMP1 in preparing medicine for treating EBV corresponding solid tumor |
| 03/26/2008 | CN101147800A Casein phosphopeptide cyclodextrin inclusion compound without bitter and its preparation method |
| 03/26/2008 | CN101147799A Medicine for treating gastritis and gastrointestinal ulcer |
| 03/26/2008 | CN101147779A Composition containing nucleotide, its preparation method and its use |
| 03/26/2008 | CN100376680C Dual target effected chimera recombinant, its construction method and application |
| 03/26/2008 | CN100376679C Protease, gene therefor and use thereof |
| 03/26/2008 | CN100376598C Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 03/26/2008 | CN100376570C Dioxolane analogs for improved inter-cellular delivery |
| 03/26/2008 | CN100376290C Antigenic peptides derived from telomerase |
| 03/26/2008 | CN100376289C Use of HCG and LH in controlled ovarian hyperstimulation |
| 03/26/2008 | CN100376288C Improvement of T cell mediated immunity |
| 03/25/2008 | US7348423 Nucleic acids encoding fusion peptides |
| 03/25/2008 | US7348414 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 03/25/2008 | US7348411 Adding a physiological coagulating agent to blood plasma; removing the transudate from said blood clot; washing blood clot with dehydrating and softening agents; drying and sterilizing; membranes provide an immediate and complete haemostasis, followed by a whole reabsorption, without risk of adhesion |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348409 Antimicrobially active peptide |
| 03/25/2008 | US7348407 Stress-responsive activator of p300 (strap) protein |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348404 Solid-phase peptide synthesis and agent for use in such synthesis |
| 03/25/2008 | US7348403 Contacting a peptide with the agent under conditions permitting formation of a phosphorus-based ester; and determining whether a phosphorus-based ester has formed between the peptide and the agent; inactivation of organophosphorus-based insecticides and chemical warfare agents |
| 03/25/2008 | US7348402 Antimicrobial peptide, its analogs and antimicrobial composition comprising them |
| 03/25/2008 | US7348401 Peptides that inhibit complement activation |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |